CONMED Corporation

Last updated

CONMED Corporation
Company typePublic company
Founded1970
Headquarters
Key people
  • Curt Hartman
  • (chairman of the board, President, and CEO)
RevenueIncrease2.svg US$1.05 billion (2022)
Increase2.svg US$ -70.9 million (2022)
Decrease2.svg US$ -80.6 million (2022)
Total assets Increase2.svg US$2.3 million (2022)
Total equity Decrease2.svg US$1.6 million (2022)
Number of employees
4,100 (2022)
Website www.conmed.com
Footnotes /references
[1]

The CONMED Corporation is a publicly traded American manufacturer of medical equipment and surgical devices, primarily in the orthopedic, laparoscopic and general surgery, and patient care areas. [2] CONMED's headquarters is in Largo, Florida. Prior to July 2022, it was in Utica, New York. [3] CONMED embraces a people-first culture that starts with a mission to support their healthcare partners and the patients they serve. They have manufacturing facilities in the United States and Mexico, offices internationally, and a vast global footprint. [4]

Contents

CONMED manufactures hundreds of products, including the AirSeal® iFS insufflator, PlumeSafe® X5™ Smoke Evacuator, BioBrace® Reinforced Bioinductive Implant, Y-Knot® All-Suture Anchor, and Argo Knotless® Suture Anchor.

History

In 1970, Eugene Corasanti (1930–2015) purchased a small medical supplied distributor in Utica, New York. He originally named the company Concor Enterprises, but later renamed it to Consolidated Medical Equipment, Inc. [5] Its first product was a disposable ECG electrode. [2] Growing through acquisitions, Corasanti served as CEO until 2006 when Curt Hartman gained the President, CEO, and Chairman of the Board position in 2014. Pat Beyer took over as President and CEO on January 1, 2025.

Today, CONMED remains an innovative company focused on helping healthcare providers enhance patient outcomes. They sponsor numerous medical education opportunities, publish a blog for HCPs, and offer leading solutions in the medical specialties they serve.

Acquisitions

References

  1. 1 2 CONMED Corporation (2023). "2022 Annual Report".
  2. 1 2 Aronovich, Hanna (December 2007). "'In-Depth Coverage'". U.S. Business Review. Vol. 8, no. 12. pp. 92–93. ISSN   1552-6313. EBSCOhost   28832089.
  3. ↑ "Utica's ConMed moved headquarters to Largo, Florida". Utica Observer Dispatch. July 20, 2022. Retrieved May 4, 2023.
  4. ↑ "Locations". CONMED corporation. Retrieved May 4, 2023.
  5. ↑ "Meet Eugene "Gene" Corasanti, CONMED's Founder". www.linkedin.com. Retrieved May 4, 2023.
  6. 1 2 3 4 5 6 7 8 9 "MarketLine Company Profile: CONMED Corp". MarketLine. August 11, 2022. EBSCOhost   159347027.
  7. ↑ "Acquisition by Conmed". The New York Times. October 20, 1995. ISSN   0362-4331 . Retrieved May 4, 2023.
  8. ↑ Christy, John H.; Waxler, Caroline (May 5, 1997). "Exit the E.R.". Forbes. Vol. 159, no. 9. p. 191. EBSCOhost   9704271568.
  9. ↑ O'Dell, John (January 19, 1995). "Birtcher to Cut 80% of Staff, Close Irvine Office if Merger OKd : Deal: The N.Y.-based competitor looking to acquire the firm wants its products and Mexican operation, not its workers. Employees expected the layoff announcement". Los Angeles Times . Retrieved November 30, 2021.
  10. ↑ "Bristol-Myers to Sell a Medical Devices Unit". The New York Times. November 28, 1997. ISSN   0362-4331 . Retrieved May 4, 2023.
  11. ↑ "COMPANY NEWS; CONMED SHARES UP ON DEAL WITH BRISTOL-MYERS". The New York Times. November 29, 1997. ISSN   0362-4331 . Retrieved May 4, 2023.
  12. ↑ "COMPANY NEWS; CONMED TO BUY BARD'S ENDOSCOPIC UNIT FOR $80 MILLION". The New York Times. August 19, 2004. ISSN   0362-4331 . Retrieved May 4, 2023.
  13. ↑ Diakantonis, Demitri (November 16, 2015). "Conmed Adds Airseal Medical Device Maker SurgiQuest". Mergers & Acquisitions Report. EBSCOhost   111147785.
  14. ↑ Sean Whooley (June 14, 2022). "Conmed completes $145M In2Bones acquisition". MassDevice.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.